A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
The final day of AACR IO highlighted the emerging frontier of glyco-immunology.
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
The second keynote session at AACR IO focused on deciphering T-cell receptors, creating TCR libraries, and rewiring cytokine signaling.
Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night...
A therapeutic HPV vaccine showed remarkable benefits for patients with high-grade cervical precancers.
Experts reflected on how clinical decision-making for treating breast cancer may change in light of the latest results shared...
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
New research into potential causes of gastric cancer is looking beyond H. pylori to other bacteria within the gastric...
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...